However, actionable genes such as BRCA1 and BRCA2 also harbor a myriad of genetic variants of unknown clinical significance (VUSs) hampering prevention and cancer management efforts, especially in African American (AA) women who report a higher frequency of VUS in BRCA1/2 [6]. The gene discussed is BRCA1; the disease is cancer.